Therapeutic Delivery – News and Features

A novel vaccination strategy utilizing small interfering RNA molecules could protect infants from COVID-19 and flu with a single shot. The study suggests that the vaccine strategy could offer continued protection even if the virus mutates.

A new immunotherapy has been developed that localizes cytokines to tumors for weeks while preserving their activity.

3D-printed films loaded with drugs could be used to kill cancer cells while minimizing the toxicity of traditional chemotherapy.

A single low dose of esketamine – the active form of the anesthetic drug, ketamine – can reduce depressive episodes when given immediately after childbirth, a new study has found.

Researchers have unveiled nanoscale voids in three dimensions, using high-powered microscopy and mathematical theory. This advancement is poised to improve the performance of many filtration materials.

A new study has used virtual reality (VR) to help reduce cancer pain for hospitalized patients, potentially providing a non-invasive and non-pharmacologic approach to improve the quality of life for people with cancer.

Scientists have developed a first-of-its-kind molecular device that controls the release of multiple small molecules using force.

The molecular mechanisms behind the action of the hepatitis B and D virus inhibitor bulevirtide have been revealed, potentially paving the way to more targeted treatments.

A clinical trial led by Weill Cornell Medicine investigators showed that a nasal spray that patients administer at home, without a physician, successfully and safely treated recurrent episodes of a condition that causes rapid abnormal heart rhythms.

Empa researchers have succeeded in 3D printing the natural material into complex shapes that could one day serve as precision insulation in microelectronics or as personalized medical implants.